These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 38230736
1. Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults. Sadlon A, Takousis P, Evangelou E, Prokopenko I, Alexopoulos P, Udeh-Momoh CM, Price G, Middleton L, Perneczky R. J Prev Alzheimers Dis; 2024; 11(1):230-240. PubMed ID: 38230736 [Abstract] [Full Text] [Related]
2. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease? Yılmaz ŞG, Erdal ME, Özge AA, Sungur MA. OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295 [Abstract] [Full Text] [Related]
3. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease. Dakterzada F, Targa A, Benítez ID, Romero-ElKhayat L, de Gonzalo-Calvo D, Torres G, Moncusí-Moix A, Huerto R, Sánchez-de-la-Torre M, Barbé F, Piñol-Ripoll G. Alzheimers Res Ther; 2020 Dec 05; 12(1):163. PubMed ID: 33278902 [Abstract] [Full Text] [Related]
4. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease. Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H. PLoS One; 2015 Dec 05; 10(5):e0126423. PubMed ID: 25992776 [Abstract] [Full Text] [Related]
5. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease. Herrera-Espejo S, Santos-Zorrozua B, Álvarez-González P, Lopez-Lopez E, Garcia-Orad Á. Mol Neurobiol; 2019 Dec 05; 56(12):8376-8391. PubMed ID: 31240600 [Abstract] [Full Text] [Related]
6. Type 2 Diabetes Mellitus and its comorbidity, Alzheimer's disease: Identifying critical microRNA using machine learning. Alamro H, Bajic V, Macvanin MT, Isenovic ER, Gojobori T, Essack M, Gao X. Front Endocrinol (Lausanne); 2022 Dec 05; 13():1084656. PubMed ID: 36743910 [Abstract] [Full Text] [Related]
7. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway. Sha S, Shen X, Cao Y, Qu L. Aging (Albany NY); 2021 Jun 04; 13(11):15285-15306. PubMed ID: 34086603 [Abstract] [Full Text] [Related]
8. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage. He H, Liu A, Zhang W, Yang H, Zhang M, Xu H, Liu Y, Hong B, Yan F, Yue L, Wang J, Xiao S, Xie Z, Wang T. J Alzheimers Dis; 2021 Jun 04; 83(2):779-790. PubMed ID: 34366343 [Abstract] [Full Text] [Related]
9. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease. Guo R, Fan G, Zhang J, Wu C, Du Y, Ye H, Li Z, Wang L, Zhang Z, Zhang L, Zhao Y, Lu Z. J Alzheimers Dis; 2017 Jun 04; 60(4):1365-1377. PubMed ID: 29036818 [Abstract] [Full Text] [Related]
10. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease. Hara N, Kikuchi M, Miyashita A, Hatsuta H, Saito Y, Kasuga K, Murayama S, Ikeuchi T, Kuwano R. Acta Neuropathol Commun; 2017 Jan 31; 5(1):10. PubMed ID: 28137310 [Abstract] [Full Text] [Related]
11. MiR-29c-3p May Promote the Progression of Alzheimer's Disease through BACE1. Cao Y, Tan X, Lu Q, Huang K, Tang X, He Z. J Healthc Eng; 2021 Jan 31; 2021():2031407. PubMed ID: 34956559 [Abstract] [Full Text] [Related]
12. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. Long JM, Ray B, Lahiri DK. J Biol Chem; 2014 Feb 21; 289(8):5184-98. PubMed ID: 24352696 [Abstract] [Full Text] [Related]
13. Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease. Wu Y, Xu J, Xu J, Cheng J, Jiao D, Zhou C, Dai Y, Chen Q. Tohoku J Exp Med; 2017 Jun 21; 242(2):129-136. PubMed ID: 28626163 [Abstract] [Full Text] [Related]
14. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study. Li F, Xie XY, Sui XF, Wang P, Chen Z, Zhang JB. Neuroscience; 2020 Apr 15; 432():240-246. PubMed ID: 32135232 [Abstract] [Full Text] [Related]
15. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease. Swarbrick S, Wragg N, Ghosh S, Stolzing A. Mol Neurobiol; 2019 Sep 15; 56(9):6156-6167. PubMed ID: 30734227 [Abstract] [Full Text] [Related]
16. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease. Chen J, Qi Y, Liu CF, Lu JM, Shi J, Shi Y. J Gene Med; 2018 Jun 15; 20(6):e3014. PubMed ID: 29543360 [Abstract] [Full Text] [Related]
17. Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease. Dong Z, Gu H, Guo Q, Liu X, Li F, Liu H, Sun L, Ma H, Zhao K. Cells; 2022 Nov 29; 11(23):. PubMed ID: 36497090 [Abstract] [Full Text] [Related]
18. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes. Kim SH, Choi KY, Park Y, McLean C, Park J, Lee JH, Lee KH, Kim BC, Huh YH, Lee KH, Song WK. Cells; 2021 Oct 09; 10(10):. PubMed ID: 34685681 [Abstract] [Full Text] [Related]
19. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo. Yang G, Song Y, Zhou X, Deng Y, Liu T, Weng G, Yu D, Pan S. Mol Med Rep; 2015 Aug 09; 12(2):3081-8. PubMed ID: 25955795 [Abstract] [Full Text] [Related]
20. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease. Kumar S, Vijayan M, Reddy PH. Hum Mol Genet; 2017 Oct 01; 26(19):3808-3822. PubMed ID: 28934394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]